Filbrandt Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$15K Buy
171
+21
+14% +$1.76K 0.01% 123
2021
Q2
$13K Hold
150
0.01% 125
2021
Q1
$11K Sell
150
-124
-45% -$9.03K 0.01% 125
2020
Q4
$19K Sell
274
-176
-39% -$11.4K 0.01% 116
2020
Q3
$26K Sell
450
-1,460
-76% -$90.8K 0.02% 105
2020
Q2
$124K Buy
1,910
+1,460
+324% +$91.9K 0.1% 57
2020
Q1
$27K Hold
450
0.03% 94
2019
Q4
$33K Buy
+450
New +$31.6K 0.03% 101

Other funds holding CVS

Filbrandt Wealth Management's CVS Position: Q3 2021 in Review

Filbrandt Wealth Management increased its CVS Health (CVS) stake by 14% in Q3 2021, buying an estimated $1.76K and bringing the position to 171 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #123.

Filbrandt Wealth Management first reported a position in CVS in Q4 2019 and has held it in 8 quarters since. The position peaked at $124K in Q2 2020. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Filbrandt Wealth Management held 171 shares of CVS Health worth $15K as of Q3 2021.
  • Filbrandt Wealth Management bought 21 CVS Health shares in Q3 2021, an estimated $1.76K.
  • CVS Health made up 0.01% of Filbrandt Wealth Management's portfolio in Q3 2021, its #123 holding.
  • Filbrandt Wealth Management first reported a position in CVS Health in Q4 2019 and has held it in 8 quarters since.
  • Filbrandt Wealth Management's CVS Health position peaked at $124K in Q2 2020.
  • 2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.